Ukr.Biochem.J. 2013; Volume 85, Issue 6, Nov-Dec, pp. 53-74


Immunosuppression under pregnancy and risks under viral infections

O. I. Kiselev

Scientific-Research Institute of Influenza, Ministry of Health
and Social Development, Russian Federation, St.-Petersburg

The paper is devoted to studying the mechanisms of combined immunosuppression in pregnant women with influenza infection to develop arrangements for controlling these processes and for decreasing mortality from this infection. In this connection the author is dwelling on the following problems:
– How are the fetus immune privilege and tolerance development provided?
– What mechanisms do underlie the functional immunosuppresion under pregnancy?
– Why are the infections especially dangerous for pregnant women?
– Is there the code of the immune system control, and do viruses use this code?
The paper deals with the problem of influence of endogenic viruses, which have penetrated the human genome more than 25 million years ago, on the great number of risks of development of various kinds of human pathologies: from infertility to pregnancy diseases; from development of malignant tumors to system pathology and autoimmune diseases.

Keywords: , , , ,


  1. Kisilev OI, Yershov FI, Bykov AT, Pokrovskiy VI. Pandemic influenza 2009/2010: antiviral therapy and treatment strategy. SPb-Moscow-Sochi, A-Print, 2010.
  2. Pokrovskiy VI, Kisilev OI. Avian influenza: the origin of infectious bio-catastrophe. Publ.Rostok, SPb,2005; 380.
  3. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998 Jul;178(1):53-60. PubMed, CrossRef
  4. McKinney WP, Volkert P, Kaufman J. Fatal swine influenza pneumonia during late pregnancy. Arch Intern Med. 1990 Jan;150(1):213-5. Review. PubMed, CrossRef
  5. Harris JW. Influenza occurring in pregnant women. JAMA. 1919;72(14):978-980. CrossRef
  6. Kisilev OI. Pregnancy, immunosuppression, influenza and placental expression of endogenous retroviruses. Publ. Rostok, SPb., 2011; 210.
  7. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, Lindstrom S, Louie JK, Christ CM, Bohm SR, Fonseca VP, Ritger KA, Kuhles DJ, Eggers P, Bruce H, Davidson HA, Lutterloh E, Harris ML, Burke C, Cocoros N, Finelli L, MacFarlane KF, Shu B, Olsen SJ; Novel Influenza A (H1N1) Pregnancy Working Group. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009 Aug 8;374(9688):451-8. PubMed, CrossRef
  8. Rote NS, Chakrabarti S, Stetzer BP. The role of human endogenous retroviruses in trophoblast differentiation and placental development. Placenta. 2004 Sep-Oct;25(8-9):673-83. Review. PubMed, CrossRef
  9. Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010 Jun;63(6):425-33. Review. PubMed, PubMedCentral, CrossRef
  10. Muir A, Lever A, Moffett A. Expression and functions of human endogenous retroviruses in the placenta: an update. Placenta. 2004 Apr;25 Suppl A:S16-25. Review. PubMed, CrossRef
  11. Noonan FP, Halliday WJ, Morton H, Clunie GJ. Early pregnancy factor is immunosuppressive. Nature. 1979 Apr 12;278(5705):649-51. PubMed, CrossRef
  12. McKinney WP, Volkert P, Kaufman J. Fatal swine influenza pneumonia during late pregnancy. Arch Intern Med. 1990 Jan;150(1):213-5. Review. PubMed, CrossRef
  13. Hartert TV, Neuzil KM, Shintani AK, Mitchel EF Jr, Snowden MS, Wood LB, Dittus RS, Griffin MR. Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol. 2003 Dec;189(6):1705-12. PubMed, CrossRef
  14. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade M, Hall R, Fowler RA; Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009 Nov 4;302(17):1872-9. PubMed, CrossRef
  15. Ebihara H, Takada A, Kobasa D, Jones S, Neumann G, Theriault S, Bray M, Feldmann H, Kawaoka Y. Molecular determinants of Ebola virus virulence in mice. PLoS Pathog. 2006 Jul;2(7):e73. PubMed, PubMedCentral, CrossRef
  16. Yaddanapudi K, Palacios G, Towner JS, Chen I, Sariol CA, Nichol ST, Lipkin WI. Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. FASEB J. 2006 Dec;20(14):2519-30. PubMed, CrossRef
  17. Belokrinitckaya TE., Trubitsina AYu., Murikova EA. Influenza A/H1N1, complicated with pneumonia, in pregnant: pregnancy course, result for mother and fetus. All-Russian scientific-practical conference “The results of influenza A/H1N1 epidemic”. Chelyabinsk, 2011: 7-9.
  18. Lapinsky SE. H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med. 2010 Apr;38(4 Suppl):e52-7. Review. PubMed, CrossRef
  19. Thellin O, Coumans B, Zorzi W, Igout A, Heinen E. Tolerance to the foeto-placental ‘graft’: ten ways to support a child for nine months. Curr Opin Immunol. 2000 Dec;12(6):731-7. Review. PubMed, CrossRef
  20. Pereira L, Maidji E, McDonagh S, Tabata T. Insights into viral transmission at the uterine-placental interface. Trends Microbiol. 2005 Apr;13(4):164-74. PubMed, CrossRef
  21. Uchide N, Toyoda H. Antioxidant therapy as a potential approach to severe influenza-associated complications. Molecules. 2011 Feb 28;16(3):2032-52. Review. PubMed, CrossRef
  22. Kanellopoulos-Langevin C, Caucheteux SM, Verbeke P, Ojcius DM. Tolerance of the fetus by the maternal immune system: role of inflammatory mediators at the feto-maternal interface. Reprod Biol Endocrinol. 2003 Dec 2;1:121. Review. PubMed, PubMedCentral, CrossRef
  23. Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerg Infect Dis. 2008 Jan;14(1):95-100. PubMed, PubMedCentral, CrossRef
  24. Kisilev OI. Genome sequence of pandemic virus A/H1N1v-2009.2011. Dimitrade Graphic Group; 163.
  25. Smorodintsev AA. Hypotheses and facts on the origin of pandemic strains of influenza A virus. Vopr Virusol. 1975 Jan-Feb;(1):105-13. Russian. PubMed
  26. Centers for Disease Control and Prevention (CDC). Novel influenza A (H1N1) virus infections in three pregnant women – United States, April-May 2009. MMWR Morb Mortal Wkly Rep. 2009 May 15;58(18):497-500.  PubMed
  27. Dubar G, Azria E, Tesnière A, Dupont H, Le Ray C, Baugnon T, Matheron S, Luton D, Richard JC, Launay O, Tsatsaris V, Goffinet F, Mignon A; French Registry on 2009 A/H1N1v during pregnancy. French experience of 2009 A/H1N1v influenza in pregnant women. PLoS One. 2010 Oct 5;5(10). pii: e13112. PubMed, PubMedCentral, CrossRef
  28. Gustafsson C. Local immune regulation in human pregnancy with focus on decidual macrophages. Linköping University Medical Dissertations. No. 1016.ISBN 978-91-85895-85-4. ISSN 0345-0082. Printed by LiU-Tryck, Linköping, Sweden, 2007.
  29. Rote NS, Chakrabarti S, Stetzer BP. The role of human endogenous retroviruses in trophoblast differentiation and placental development. Placenta. 2004 Sep-Oct;25(8-9):673-83. Review. PubMed, CrossRef
  30. Kisilev OI. Chemo drugs and influenza chemotherapy. SPb.,Publ. Rostok, 2012: 269.
  31. Sigalov AB. Interaction between HIV gp41 fusion peptide and T cell receptor: putting the puzzle pieces back together. FASEB J. 2007 Jun;21(8):1633-4; author reply 1635. PubMed, CrossRef
  32. Sigalov AB. Novel mechanistic insights into viral modulation of immune receptor signaling. PLoS Pathog. 2009 Jul;5(7):e1000404. PubMed, PubMedCentral, CrossRef
  33. Blinov VM. «Dormant» immunosuppressive domains (ISD) in filoviruses: activation of «Dormant» filoviruses by endogenous retroviruses. Regime of access:
  34. Schlecht-Louf G, Renard M, Mangeney M, Letzelter C, Richaud A, Ducos B, Bouallaga I, Heidmann T. Retroviral infection in vivo requires an immune escape virulence factor encrypted in the envelope protein of oncoretroviruses. Proc Natl Acad Sci USA. 2010 Feb 23;107(8):3782-7. PubMed, PubMedCentral, CrossRef
  35. Mangeney M, Renard M, Schlecht-Louf G, Bouallaga I, Heidmann O, Letzelter C, Richaud A, Ducos B, Heidmann T. Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci USA. 2007 Dec 18;104(51):20534-9. PubMed, PubMedCentral
  36. Vargas A, Moreau J, Landry S, LeBellego F, Toufaily C, Rassart E, Lafond J, Barbeau B. Syncytin-2 plays an important role in the fusion of human trophoblast cells. J Mol Biol. 2009 Sep 18;392(2):301-18. PubMed, CrossRef
  37. Kiselev OI, Blinov VM, Pisareva M, Grudinin M. Genomic structure of highly pathogenic influenza H5N1 virus. Identification of Ebola-like immunosuppressive domain in NS2 protein. Options for the Control of Influenza VI. Proceedings of the International Conference on Options for the Control of Influenza VI held in Toronto, Ontario, Canada / Ed. J. M. Katz. June 17-23, 2007. P. 252-253.
  38. Cytokine storm – reference.
  39. Coleman JR. The PB1-F2 protein of Influenza A virus: increasing pathogenicity by disrupting alveolar macrophages. Virol J. 2007 Jan 15;4:9. PubMed, PubMedCentral, CrossRef
  40. McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, Bennink J, Yewdell JW, McCullers JA. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe. 2007 Oct 11;2(4):240-9. PubMed, PubMedCentral, CrossRef
  41. Kisilev OI. Peptides – complexons of immunosuppressive domains of viral and cellular proteins.  Patent application, 2012.
  42. Amon MA, Manolios N. Hypothesis: TCR signal transduction–A novel tri-modular signaling system. Mol Immunol. 2008 Feb;45(4):876-80. PubMed, CrossRef
  43. Call ME, Pyrdol J, Wiedmann M, Wucherpfennig KW. The organizing principle in the formation of the T cell receptor-CD3 complex. Cell. 2002 Dec 27;111(7):967-79. PubMed, PubMedCentral, CrossRef
  44. Call ME, Schnell JR, Xu C, Lutz RA, Chou JJ, Wucherpfennig KW. The structure of the zetazeta transmembrane dimer reveals features essential for its assembly with the T cell receptor. Cell. 2006 Oct 20;127(2):355-68. PubMed, PubMedCentral, CrossRef]
  45. Call ME, Wucherpfennig KW. Common themes in the assembly and architecture of activating immune receptors. Nat Rev Immunol. 2007 Nov;7(11):841-50. Review. PubMed, CrossRef
  46. Call ME, Wucherpfennig KW, Chou JJ. The structural basis for intramembrane assembly of an activating immunoreceptor complex. Nat Immunol. 2010 Nov;11(11):1023-9. PubMed, PubMedCentral, CrossRef
  47. Guo H, Kumar P, Moran TM, Garcia-Sastre A, Zhou Y, Malarkannan S. The functional impairment of natural killer cells during influenza virus infection. Immunol Cell Biol. 2009 Nov-Dec;87(8):579-89. PubMed, PubMedCentral, CrossRef
  48. Warning JC, McCracken SA, Morris JM. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction. 2011 Jun;141(6):715-24.  PubMed, CrossRef
  49. Taylor DD, Gercel-Taylor C.  1141420984 Placental exosome suppression of T cell activation and differential target of T cell subsets. Am J  Reprod  Immunol.  2006;55(6):401-402. CrossRef
  50. Taylor DD, Akyol S, Gercel-Taylor C. Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol. 2006 Feb 1;176(3):1534-42. PubMed, CrossRef
  51. Hedlund M, Stenqvist AC, Nagaeva O, Kjellberg L, Wulff M, Baranov V, Mincheva-Nilsson L. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J Immunol. 2009 Jul 1;183(1):340-51. PubMed, CrossRef
  52. Chamley L. F1000 Women’s Health. 29 Jul 2009. New Finding.
  53. Luo SS, Ishibashi O, Ishikawa G, Ishikawa T, Katayama A, Mishima T, Takizawa T, Shigihara T, Goto T, Izumi A, Ohkuchi A, Matsubara S, Takeshita T, Takizawa T. Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod. 2009 Oct;81(4):717-29. PubMed, CrossRef
  54. Guo H, Kumar P, Malarkannan S. Evasion of natural killer cells by influenza virus. J Leukoc Biol. 2011 Feb;89(2):189-94. Review. PubMed, PubMedCentral, CrossRef
  55. NKG2D and its Ligands. Regime of access:
  56. González S, Groh V, Spies T. Immunobiology of human NKG2D and its ligands. Curr Top Microbiol Immunol. 2006;298:121-38. Review. PubMed, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.